Intelligence / Healthtech & medtech market map / Medical devices / Surgical and interventional devices / Interventional cardiology, structural heart and electrophysiology device franchises
Interventional cardiology, structural heart and electrophysiology device franchises
Devices sold for catheter-based and transcatheter treatment of cardiovascular disease: diagnostic and interventional catheters, guidewires, balloon and stent systems, transcatheter valve and occluder devices, electrophysiology mapping and ablation systems, and their consumables. Job is to expand and treat cardiovascular cases in the cath lab and EP suite.
- Level
- Niche
- Segmented by
- Customer type
- Buyers
- Hospitals (cath labs, structural heart programmes, EP labs) and ambulatory/office-based cardiovascular providers
- Buying centre
- Heart centre or interventional cardiology leadership with cath lab management, structural heart team, procurement and contracting; key opinion leaders drive brand selection
- Growth of transcatheter valve and structural heart procedures
- Expansion of complex PCI and AF ablation case volumes
- New device indications and trial readouts
- Hospital strategy to build or expand cardiovascular service lines
- Replacement of legacy EP mapping and imaging platforms
- Long learning curves and credentialing requirements for new platforms
- High per-procedure device cost under reimbursement pressure
- Capacity constraints in cath labs and EP suites
- Competitive bidding with large incumbent portfolios
How this was sized
Not sized yet
No source sizes cardiovascular intervention separately. Proxy: [6] identifies North America as 41.44% of the USD 620bn 2025 global device market and surgical/endoscopy/robotic as the largest device type at 31.00%; cardiovascular intervention is a subset of that 31% with no sourced share. Bottom-up: assume cardiovascular intervention is 20-30% of the USD 200bn 2026 surgical/interventional pool, giving USD 40bn-60bn for 2026. Arithmetic: 200bn x 20% = 40bn; 200bn x 30% = 60bn. Low confidence: the 20-30% share is an assumption; [7] and [10] note that manufacturers are directing investment toward higher-growth cardiovascular intervention categories and cite Boston Scientific's agreement to acquire Penumbra, but give no segment revenue.
- Medical Device Market Projected to Scale to $1.11 Trillion by 2035, Assesses SRI
strategicrevenueinsights.com · 2026-10-18 - Global Market for Medical Devices, 16th Edition (2026–2031) - Science and Medicine Group
scienceandmedicinegroup.com - Global Market for Medical Devices, 16th Edition
marketresearch.com
Alongside it in Surgical and interventional devices
// Sell into Interventional cardiology, structural heart and electrophysiology device franchises